NCT05261152 - S. Boulardii in Prevention of Antibiotic-associated Diarrhea in Hospitalized Adults With Respiratory Tract Infections | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 1, 2017

Primary Completion Date

December 1, 2018

Study Completion Date

December 31, 2018

Conditions

Prevention & ControlDiarrhea Caused by DrugRespiratory Infection BacterialAnti-Bacterial Agents

Interventions

DRUG

drug product: capsules are containing S. boulardii, administered twice daily (250 mg)

Randomisation: 1:1 Capsules containing S. boulardii twice daily (250 mg) or indistinguishable capsules containing placebo twice daily.

Trial Locations (2)

Clinical Center of Serbia, Belgrade

Institute for Pulmonary Diseases of Vojvodina, Novi Sad